Sign in

Epigenetics Drugs And Diagnostics Market Growth Accelerated By Emerging Personalized Medicine Approach

kiran gire
Epigenetics Drugs And Diagnostics Market Growth Accelerated By Emerging Personalized Medicine Approach

Epigenetics drugs and diagnostic technologies are revolutionary tools used in personalized medicine and biomedical research. They enable identification of molecular biomarkers for detection of diseases like cancer at an early stage and enable targeted drug therapies. Advantages include non-invasive detection, high sensitivity and specificity. The global Epigenetics Drugs and Diagnostic Technologies Market is estimated to be valued at US$ 12.91 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing scope of personalized medicine is one of the key trends driving the growth of the epigenetics drugs and diagnostic technologies market. Epigenetic tools enable understanding of how environmental factors interact with the genome to switch genes on or off and affect disease risk. This helps in developing personalized drug therapies and predictive, preventive and personalized medicine approaches. Various companies are focusing on development of epigenetic diagnostic tools and drugs for precision medicine in disease areas like oncology. For instance, Johnson & Johnson is developing an epigenetic therapy JNJ-64042709 for treating solid tumors. Such advancements are expected to boost the adoption of epigenetics-based personalized treatment over the forecast period.

Segment Analysis

The global Epigenetics Drugs and Diagnostic Technologies market is dominated by drugs and technologies sub segments. The drugs sub segment dominates the market currently due to increasing approvals and demand for targeted therapies in various cancer indications. Epigenetics drugs treat cancer by modifying gene activity without permanent changes to the DNA sequence. Targeted therapies are more effective and preferred treatment options over conventional chemotherapy thus driving the drugs sub segment growth.

Key Takeaways

The global Epigenetics Drugs and Diagnostic Technologies market analysis is expected to witness high growth during the forecast period of 2024 to 2031. The market size for 2024 is estimated to be US$ 12.91 Bn.

Regional analysis

The North America region currently dominates the global Epigenetics Drugs and Diagnostic Technologies market due to presence of major players, high adoption of advanced therapies and strong healthcare infrastructure in countries like United States and Canada. The Asia Pacific region is expected to witness highest growth during the forecast period due to growing healthcare expenditures, rising cancer incidences and increasing investments by key players in developing markets of China and India.

Key players

operating in the Epigenetics Drugs and Diagnostic Technologies market are Canon, Brother Industries, Hewlett-Packard Development, Printronix, Ricoh Digital Painting Company, Inca Digital Printers Limited, Mimaki Engineering, Electronics For Imaging, Roland Dg Corporation, Durst Phototechnik AG, Xerox Corporation, and Seiko Epson Corporation. Canon and Brother Industries currently dominate the market due to wide product portfolio and global presence. The other players are focusing on new product launches and geographic expansions to increase their market shares in coming years.

Get more insights on this topic: https://www.ukwebwire.com/epigenetics-drugs-and-diagnostic-technologies-market-industry-insights-trends-epigenetics-drugs-and-diagnostic-technologies-market/

Explore more information on this topic, Please visit: https://ceocolumn.com/tech/what-are-field-programmable-gate-arrays-fpgas/

kiran gire
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more